Schilsky M L
Department of Medicine and Surgery, Yale University Medical Center, New Haven, CT, USA.
Transplant Proc. 2011 Apr;43(3):879-83. doi: 10.1016/j.transproceed.2011.01.109.
Survival of patients presenting with acute liver failure (ALF) has improved over the past decades due to earlier disease recognition, advances in supportive measures, intensive care, and liver transplantation. Liver assist devices may have a role in future care of patients with ALF, bridging them to recovery or to transplantation. A multidisciplinary team approach to the care of patients with ALF is critical for achieving good patient outcomes.
在过去几十年中,由于疾病的早期识别、支持措施的进步、重症监护以及肝移植技术的发展,急性肝衰竭(ALF)患者的生存率有所提高。肝辅助装置可能在未来ALF患者的治疗中发挥作用,帮助他们恢复或进行移植。采用多学科团队方法来治疗ALF患者对于取得良好的治疗效果至关重要。